Flossbach Von Storch
CELG

Flossbach Von Storch’s Celgene Corp CELG Stock Holding History

Flossbach Von Storch’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,600
Closed -$137K – 109
2014
Q2 		$137K Buy
+1,600
New +$122K ﹤0.01% 98

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Flossbach Von Storch's CELG Position: Q3 2014 in Review

Flossbach Von Storch sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 1,600 shares — an estimated $137K sold.

Flossbach Von Storch first reported a position in CELG in Q2 2014 and held it in 1 quarter. The position peaked at $137K in Q2 2014. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • Flossbach Von Storch reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
  • Flossbach Von Storch sold 1,600 Celgene Corp shares in Q3 2014, an estimated $137K.
  • Flossbach Von Storch first reported a position in Celgene Corp in Q2 2014 and held it in 1 quarter.
  • Flossbach Von Storch's Celgene Corp position peaked at $137K in Q2 2014.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Flossbach Von Storch's 13F filing for Q3 2014, filed 23 Oct 2014.